US$ 22.67
glp 1 drugs and vision loss Possible Link Between GLP-1 RA Medications & Eye Health Study finds rare vision issues
Description
So far, several unimolecular dual and triple agonists are in clinical evaluation and as of today, the improved metabolic efficacy does not seem to be compromised by reduced safety [25].

2025 May;46(5):422-436

doi: 10.1016/j.jcjd.2019.09.003 110 HusainMBirkenfeldALDonsmarkMDunganKEliaschewitzFGFrancoDRet al
Healthcare Costs The widespread use of GLP-1 medications also has significant implications for healthcare costs

A 30-week randomized non-inferiority study comparing 2 mg once-weekly EX-LAR with 10 g twice-daily EX in 295 patients with T2DM
